Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections

Despite advances in antimicrobial therapy and even the advent of some effective vaccines, Pseudomonas aeruginosa (P. aeruginosa) remains a significant cause of infectious disease, primarily due to antibiotic resistance. Although P. aeruginosa is commonly treatable with readily available therapeutics...

Descripción completa

Detalles Bibliográficos
Autores principales: Proctor, Luke L., Ward, Whitney L., Roggy, Conner S., Koontz, Alexandra G., Clark, Katie M., Quinn, Alyssa P., Schroeder, Meredith, Brooks, Amanda E., Small, James M., Towne, Francina D., Brooks, Benjamin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698887/
https://www.ncbi.nlm.nih.gov/pubmed/34943742
http://dx.doi.org/10.3390/antibiotics10121530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698887/
https://www.ncbi.nlm.nih.gov/pubmed/34943742
http://dx.doi.org/10.3390/antibiotics10121530

Ejemplares similares